Obesity market could be worth $50B in 2030

While reimbursement and education challenges persist, drugmakers like Eli Lilly and Novo Nordisk are poised to unlock a global obesity ...

Related Keywords

United States ,American ,Eli Lilly ,Zealand Pharma ,Morgan Stanley ,American Medical Association ,Securities Research ,Morgan Stanley Research ,European Commission ,Novo Nordisk ,Regor Therapeutics ,Mizuho Securities ,